Top pick for banking + investing in one app
- Trade stocks, options, ETFs and mutual funds
- Access to a financial planner
- All-in-one app for banking and investing
- Automated investing available
Top pick for banking + investing in one app
Get 12 free shares
Top pick for bank-integrated investing
Arm Holdings is a UK-based semiconductor design company founded in 1990 as Advanced RISC Machines Ltd, by Jamie Urquhart, Mike Muller, Tudor Brown, Lee Smith, John Biggs, Harry Oldham, Dave Howard, Pete Harrod, Harry Meekings, Al Thomas, Andy Merritt and David Seal. Arm architects, develops and licenses central processing unit (CPU), graphic processing unit (GPU) and neural processing unit (NPU) products and related technologies for semiconductor companies and original equipment manufacturers (OEMs). Japanese investment holding company, SoftBank, acquired Arm in 2016 and took the company private after nearly 20 years as a public company. Arm once again went public on September 14, 2023. According to Arm, it’s shipped more than 250 billion Arm-based chips since its inception. The company also announced on September 5, 2023, that it had entered into a new long-term agreement with Apple Inc. The partnership gives Apple access to the Arm architecture, which it uses in its iPhone and Mac chips, beyond 2040.
May 6, 2026: Arm Holdings reported fourth-quarter and full-year fiscal 2026 results on 6 May 2026, with record quarterly revenue of $1.49b (up 20%) and full-year revenue of $4.92b (up 23%); shares fell after it warned it could not secure enough manufacturing capacity for its new in-house CPU.
Looking for other options? Check out these similar products.
How we picked theseThe Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on eight different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $191.80 |
|---|---|
| 52-week range | $100.02 - $452.70 |
| 50-day moving average | $258.73 |
| 200-day moving average | $228.93 |
| Wall St. target price | $290.71 |
| PE ratio | 212.3402 |
| Dividend yield | N/A |
| Earnings per share (TTM) | $0.97 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $196.79 from 2026-11-02
| 1 week (2026-10-30) | -4.46% |
|---|---|
| 1 month (2026-10-06) | -34.96% |
| 3 months (2026-08-06) | -31.36% |
| 6 months (2026-05-06) | -17.07% |
| 1 year (2025-11-06) | 24.35% |
|---|---|
| 2 years (2024-11-06) | 36.02% |
| 3 years (2023-11-06) | 270.60% |
| 5 years (2021-11-02) | N/A |
Valuing Arm stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Arm's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Arm's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 212x. In other words, Arm shares trade at around 212x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
However, Arm's P/E ratio is best considered in relation to those of others within the semiconductors industry or those of similar companies.
Arm's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.6915. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Arm's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
However, it's sensible to consider Arm's PEG ratio in relation to those of similar companies.
Arm's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.1 billion.
The EBITDA is a measure of a Arm's overall financial performance and is widely used to measure a its profitability.
To put Arm's EBITDA into context you can compare it against that of similar companies.
| Revenue TTM | $5.2 billion |
|---|---|
| Operating margin TTM | 7.6% |
| Gross profit TTM | $5 billion |
| Return on assets TTM | 5.42% |
| Return on equity TTM | 13.35% |
| Profit margin | 20.25% |
| Book value | $8.08 |
| Market Capitalization | $220 billion |
| EBITDA | $1.1 billion |
TTM: trailing 12 months
We're not expecting Arm to pay a dividend over the next 12 months.
You may also wish to consider:
Over the last 12 months, Arm's shares have ranged in value from as little as $100.02 up to $452.7. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Arm's is 3.789. This would suggest that Arm's shares are significantly more volatile than the average for this exchange and represent a higher risk.
To put Arm's beta into context you can compare it against those of similar companies.
Steps to add Fundrise Innovation Fund shares to your portfolio, with historical pricing, volatility and earnings metrics.
Everything we know about the Anthropic IPO, plus information on how to buy in.
Figma is officially public under the ticker FIG. Learn how to buy Figma stock, compare brokers and explore if it fits your investment strategy.
Looking to jump on the AI bandwagon? Here’s how you can invest in ChatGPT and its parent company OpenAI.
Steps to owning and managing MSTR, with 24-hour and historical pricing before you buy.
Steps to owning and managing PLTR, with 24-hour and historical pricing before you buy.
Steps to owning and managing NVDA, with 24-hour and historical pricing before you buy.
Steps to owning and managing GOOGL, with 24-hour and historical pricing before you buy.
Steps to owning and managing AMZN, with 24-hour and historical pricing before you buy.
Steps to owning and managing AAPL, with 24-hour and historical pricing before you buy.
Finder is a comparison platform and information service designed to help you make better decisions. To keep our service free, we receive compensation from the companies whose products or services we feature on our site.
We may be paid when you click on a link, submit an application, or open an account.
Our commercial arrangements affect which products we write about, as well as the inclusion, order, position and placement of products on our site. They do not influence our independent assessments or editorial views, which are based on research and expert analysis conducted by our editorial team.
The inclusion of a provider or product in our content, or the order in which products appear in tables or lists, is not an endorsement or recommendation from us.
We compare a wide range of products, providers and services, but we don't cover the whole market. Not every company or offer available is included on our site, and other options may be available to you.
The information we provide is general in nature and is not financial, investment, tax or legal advice. Consider your own circumstances and read the provider's terms and conditions before making a decision.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.